It also highlighted changes in other markers that are not often monitored in preclinical studies (i.e., MIP3α/CCL20, LT-α, CD40L, IL-31, IL-27, GM-CSF, etc.), but that do have biological relevance in human IBD [32,33,34,35,36]. The gene discussed is CSF2; the disease is inflammatory bowel disease.